Is a New AI Model the Catalyst Alphabet Stock Needed?
Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...
Alphabet Is A Massive Cash Flow Machine With An Under-Leveraged Balance Sheet: Analyst
WestPark Capital analyst Curtis Shauger initiated coverage on Alphabet (NASDAQ:GOOG) on Tuesday with a Buy rating and a price ...
My Top Artificial Intelligence (AI) Stocks to Buy Right Now
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Alphabet spinout Isomorphic Labs raises $600M for its AI drug design engine
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Alphabet: Progress In AI Cannot Be Ignored For Long
Alphabet's recent AI progress and Waymo expansion signal growth potential. Learn why GOOG stock is trading cheap and could be ...
Alphabet: Poised For Explosive Returns After Selloff
Alphabet's diverse, high-margin growth engines like AI, Cloud & YouTube drive strong revenue growth. Click here to read my ...
Fierce Biotech1d
Alphabet's AI biotech Isomorphic Labs hauls in $600M to power next-gen drug design model
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Google-Backed AI Drug Discovery Startup Raises $600 Million
Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.